Evidence map›Paper›PMID 30200267›Full record

ArticleNanomaterials (Basel, Switzerland)2018

Development of Magnetically Active Scaffolds for Bone Regeneration.

Esperanza Díaz, Mᵃ Blanca Valle, Sylvie Ribeiro, Senentxu Lanceros-Mendez, José Manuel Barandiarán

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. 3D Cytocompatible Composites of PCL/magnetite.Materials (Basel, Switzerland) · 2019
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Esperanza DíazEscuela de Ingeniería de Bilbao, Departamento de Ingeniería Minera, Metalúrgica y Ciencia de Materiales, Universidad del País Vasco (UPV/EHU), 48920 Portugalete, Spain. esperanza.diaz@ehu.eus.ORCID 0000-0001-6483-6593
Mᵃ Blanca ValleFacultad de Ciencia y Tecnología, Departamento de Electricidad y Electrónica, University of the Basque Country (UPV/EHU), Sarriena s/n, 48940 Leioa, Spain. mb.valle@ehu.eus.
Sylvie RibeiroCentro/Departamento de Física, Universidade do Minho, 4710-057 Braga, Portugal. s.ribeiro@bcmaterials.es.
Senentxu Lanceros-MendezBCMaterials, Basque Centre for Materials, Applications and Nanostructures, UPV/EHU Science Park, 48940 Leioa, Spain. slm@bcmaterials.es.
José Manuel BarandiaránBCMaterials, Basque Centre for Materials, Applications and Nanostructures, UPV/EHU Science Park, 48940 Leioa, Spain. jm.barandiaran@ehu.eus.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This work reports on the synthesis, with the thermally induced phase separation (TIPS) technique, of poly (l-lactide) (PLLA) scaffolds containing Fe-doped hydroxyapatite (FeHA) particles for bone regeneration. Magnetization curves and X-ray diffraction indicate two magnetic particle phases: FeHA and magnetite Fe₃O₄. Magnetic nanoparticles (MNPs) are approximately 30 ± 5 nm in width and 125 ± 25 nm in length, and show typical ferromagnetic properties, including coercivity and rapid saturation magnetization. Scanning electron microscopy (SEM) images of the magnetic scaffolds reveal their complex morphology changes with MNP concentration. Similarly, at compositions of approximately 20% MNPs, the phase separation changes, passing from solid⁻liquid to liquid⁻liquid as revealed by the hill-like structures, with low peaks that give the walls in the SEM images a surface pattern of micro-ruggedness typical of nucleation mechanisms and growth. In vitro degradation experiments, carried out for more than 28 weeks, demonstrated that the MNPs delay the scaffold degradation process. Cytotoxicity is appreciated for FeHA content above 20%.

Indexed as

cytotoxicityFe-doped hydroxyapatite">l-lactide)magnetismpoly (scaffolds

Identifiers

PMID30200267
PMCPMC6163623

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.